Question 1

What are the most cited papers from Luye Pharma (Switzerland)?

Accepted Answer

The most cited paper from Luye Pharma (Switzerland) is "Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study" (Patrick M. Moriarty, Eli M. Roth, Adam D. Karns et al., 2014), with 64 citations. Next come "Intercomparison of eleven condensation nucleus counters" (17) and "Liquid crystal display as spatial light modulator for diffractive optical elements and the reconstruction of digital holograms" (17).

Question 2

Which research topics does Luye Pharma (Switzerland) publish most on?

Accepted Answer

By volume in 2022-now: Cancer, Lipids, and Metabolism, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research and Mental Health Research Topics.

Question 3

Which keywords describe research at Luye Pharma (Switzerland)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Antioxidant, Herbal Medicine, Antiviral, Cancer, Pharmacology, Glycyrrhizin, Licorice and Anti-inflammatory.

Question 4

Which fields of science does Luye Pharma (Switzerland) work in?

Accepted Answer

In all years, 45% of research at Luye Pharma (Switzerland) is in Physical Sciences, 27% in Life Sciences. Its largest fields are Engineering (26%), Medicine (18%), Pharmacology, Toxicology and Pharmaceutics (10%). It does 1.4× the world's share of Life Sciences.

Question 5

Is Luye Pharma (Switzerland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 168% higher than in 2018-2021.